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ABSTRACT 
Juvenile idiopathic arthritis (JIA) is an inflammatory joint disease in children that can 
involve the temporomandibular joint (TMJ), consequently affect craniofacial growth, 
jaw function creating discomfort and pain. It is possible that the TMJ is one of the 
most frequently involved joints in JIA. Earlier studies have often comprised a limited 
number of patients and different classification criteria have been used. The 
introduction of new medical therapies might have influenced the prognosis for JIA in 
the jaw system. The overall aim was to investigate how JIA manifests in the jaws by 
evaluating symptoms from the orofacial region in adults once diagnosed with JIA. 
Also investigate clinical, subjective and radiological involvement of the TMJ on 
panoramic radiographs of children with JIA. Facial growth as judged on 
cephalometric radiographs was also evaluated. All the findings were related to 
medical treatment and disease activity over time. We found that adult patients with 
JIA report more pain and dysfunction in the orofacial region compared with healthy 
controls. Our study shows associations between orofacial signs, symptoms and 
overall disease activity in children with JIA. TMJ condylar alterations on panoramic 
radiographs are fairly common and active disease appears to increase the risk of 
alterations despite medication. Children with JIA seems to have a changed growth 
pattern compared with a healthy reference group and patients with condylar 
alterations have more retrognathia and posterior rotaded mandibles. An early TMJ 
diagnosis in children with JIA is important in order to prevent a negative effect on 
the TMJs. There is a lack of consensus on when and how to treat JIA in terms of the 
TMJ. Longer follow-up studies and further prospective studies with the emphasis on 
the progress of TMJ arthritis and the influence on facial growth are necessary.  
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temporomandibular joint 
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SAMMANFATTNING PÅ SVENSKA 
Juvenil idiopatisk artrit (JIA) är den vanligaste inflammatoriska 
ledsjukdomen som drabbar barn och ungdomar under 16 år. I Sverige är 
incidensen 14/100000 och prevalensen 1 på 1000. JIA karaktäriseras av 
inflammation i en eller flera leder med symptom i form av smärta och 
tilllväxtstörningar. Man har sett att käkleden är en av de mest drabbade 
lederna. En påverkan på käkleden kan ge smärta, försämrad 
underkäksfunktion och störd tillväxt. Det är inte alltid inflammationen i 
käkleden ger några kliniska symptom varför den ibland kallas ”tysta leden”. 
Detta kan leda till att grava inflammatoriska förändringar kan hinna uppstå 
innan sjukdomen upptäcks. Genom en panoramaröntgen undersökning kan 
man se förändringar på käkledshuvudet och genom en profilröntgen 
(kefalometri) kan man studera tillväxtmönster av under- och överkäke. Den 
farmakologiska behandlingen syftar till att minska smärta och dämpa 
inflammationen i lederna. Syftet med avhandlingen var att utvärdera 
manifestationer i käkar hos barn och vuxna med JIA genom en enkätstudie. 
Ett annat syfte var att genom en retrospektiv genomgång av medicinska och 
odontologiska journaldata, granskning av befintliga röntgenutredningar i 
form av panorama och profilröntgen analysera och se eventuella samband 
mellan kliniska symptom och kliniska tecken från det orofaciala området. Vi 
vill också undersöka käkledsförändringar på panoramaröntgen, 
tillväxtförändringar på profilröntgen samt analysera effekten av medicinering 
och sjukdomsaktivitet över tid. Vi fann att vuxna som tidigare diagnosticerats 
med JIA har en ökad förekomst av besvär från det orofaciala området än 
motsvarande friska kontroller. Vi har sett att det finns ett samband mellan 
symptom och kliniska tecken och sjukdomsaktivitet hos barn med JIA. En 
aktiv sjukdom över tid ökar risken för käkledsförändringar trots 
medicinering. Käkledstillväxten hos barn med JIA var annorlunda mot en 
referensgrupp av friska svenska barn. De barn som hade käkledsförändringar 
på panoramaröntgen hade också ett förändrat tillväxtmönster av 
ansiktstillväxten. Det är viktigt att utreda och följa upp patienter med JIA 
avseende smärta och käkfunktion för att tidigt upptäcka inflammatoriska 
förändringar i käkleden och undvika besvär och tillväxtstörningar av käkarna. 
Det finns idag ingen consensus över hur vi ska följa och behandla käkleden 
på patienter med JIA därför är större prospektiva studier i området av 
betydelse 
Anna-Lena Cedströmer 
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1 INTRODUCTION 
Juvenile idiopatic arthritis (JIA) is primarily an inflammatory joint disease 
that affects children and in many cases involves the temporomandibular joint 
(TMJ). The consequence can be a change in craniofacial growth, together 
with affected jaw function that can create discomfort and pain. 
JIA is the most common systemic autoimmune disease in children and 
adolescents and the incidence varies in different countries. In a Nordic 
population-based, study the incidence in Sweden was 14/100,000 (Berntson 
et al. 2003). Worldwide, the incidence varies greatly (Ravelli et al. 2007). 
The course of the disease fluctuates. The prevalence in Sweden is one in 
1,000 children (Andersson Gäre et al. 1992, Berntson et al. 2003). Girls are 
more susceptible than boys, with a ratio of 3:1 (Andersson GGde et al. 1992). 
The course of the disease is very heterogeneous. 
 
1.1. Evolution of classification in childhood 
arthritis 
Mayer S. Diamantberger first distinguished chronic arthritis in children from 
adult arthritis in his doctoral thesis in 1891 (Diamantberger 1890). In 1897, 
the British physician George F. Still, published a paper in which he reported 
that arthritis in children differed in clinical respects from rheumatoid arthritis 
(RA) in adults (Still 1897). Since then, several publications have addressed 
the differences between chronic arthritis in childhood and RA in adults. 
Chronic childhood arthritis is a group of several distinct diseases and the 
diagnosis is based on clinical assessments, without pathognomonic findings 
or objective confirmatory laboratory tests, and the exclusion of other 
diseases. (Nistala et al. 2009, Prakken et al. 2009, Frosch et al. 2008).  
Classifications of the disease have varied over time and in different parts of 
the world. In recent decades, different classifications have been primarily 
suggested.  
 
In the United States and Canada, a definition of juvenile rheumatoid arthritis 
(JRA) was presented and revised in 1977 by the American College of 
Rheumatology (ACR). They described JRA as an idiopathic arthritis with a 
minimum of six weeks’ duration in an individual under the age of 16 years. 
After six months’ of duration, the disease is divided into systemic, 
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pauciarticular (one to four joints affected) or polyarticular (more than five 
joints affected) (Brewer et al. 1977).  
 
In the European classification, which was also presented in 1977, the 
European League Against Rheumatism (EULAR) used the term “juvenile 
chronic arthritis (JCA)”. The idiopathic condition has to last for three months 
in an individual less than 16 years of age. The criteria were listed as systemic, 
pauciarticular and polyarticular. In order to encompass all forms of chronic 
inflammatory arthritis, it also included juvenile ankylosing spondylitis (JAS), 
juvenile psoriatic arthritis (JPsA) and arthropathy associated with 
inflammatory bowel disease (IBD) (EULAR 1977).  
  
In 1995, the Paediatric Standing Committee of the International League of 
Associations for Rheumatology (ILAR) devised the present classification, 
which is used worldwide (Petty et al. 2004, Southwood et al. 1997). The 
ILAR committee grouped the different categories of disease under the 
umbrella term “juvenile idiopathic arthritis (JIA)”. The criteria were revised 
in 1997 and 2001 (Petty et al. 2004). The condition must last for more than 
six weeks and appear before the age of 16 (Fink et al. 1995, Martini et al. 
2010, Ravelli et al. 2007, Cassidy et al. 1986). The ILAR criteria divide 
clinically distinguishable disease groups into seven categories based, first and 
foremost on the number of joints involved, and they are now used worldwide. 
Importantly, the ILAR classification represents the first attempt to reach an 
international consensus, aiming to facilitate the comparison of scientific 
studies. Table 1 summarises the definition of the seven categories of JIA 
according to the ILAR classification criteria. 
Anna-Lena Cedströmer 
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Table 1. Classification of juvenile idiopathic arthritis 
Category Definition 
Systemic arthritis Fever lasting at least two weeks and arthritis in ≥ 1 joint, plus 
one or more of the following: erythematous rash, generalized 
lymph node enlargement, hepatomegaly and/or splenomegaly 
serositis 
Exclusions: a, b, c, d 
Oligoarthritis Arthritis affecting ≤ 4 joints during the first six months of disease. 
There are two subcategories: 
Persistent = affecting ≤ 4 joints throughout the disease 
Extended = affecting > 4 joints after the first six months of 
disease 
Exclusions: a, b, c, d, e 
Polyarthritis, RF- Arthritis affecting ≥ 5 joints during the first six months of disease, 
RF negative 
Exclusions: a, b, c, d, e 
Polyarthritis, RF+  Arthritis affecting ≥ 5 joints during the first six month of disease, 
RF positive at least 2x on tests at least three months apart. 
Exclusions: a, b, c, e 
Psoriatic arthritis  Arthritis + psoriasis, or arthritis and at least two of the following: 
dactylitis, nail pitting or onycholysis, psoriasis in a first-degree 
relative 
Exclusions: b, c, d, e 
Enthesitis-related  
arthritis  
Arthritis + enthesitis or arthritis or enthesitis with at least two of 
the following: 
presence/history of sacroiliac joint tenderness and or 
inflammatory lumbosacral pain 
HLA-B27+ 
Onset of arthritis in a male over six years of age 
Acute (symptomatic) anterior uveitis 
History of ankylosing spondylitis, enthesitis-related arthritis, 
sacroiliitis with inflammatory bowel disease or acute anterior 
uveitis in a first-degree relative 
Exclusions: a, d, e  
Undifferentiated arthritis Arthritis that fulfils criteria in no category or in two or more of the 
above categories 
The principle of this classification is that all the categories of JIA are mutually exclusive. This 
principle is reflected in the list of possible exclusions for each category: 
a) Psoriasis or a history of psoriasis in the patient or a first-degree relative 
b) Arthritis in an HLA-B27-positive male beginning after his sixth birthday 
c) Anlykosing spondylitis, enthesitis-related arthritis, sacroiliitis with inflammatory bowel 
disease or acute anterior uveitis or a history of one of these disorders in a first-degree relative 
d) The presence of IgM rheumatoid factor and at least two occasions at least three months 
apart 
The presence of systemic JIA in the patient 
RF = Rheumatoid Factor 
Adapted from Petty et al. (2004) 
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Systemic JIA is characterised by prominent systemic features, such as fever, 
rash and serositis (Ravelli et al. 2007). Today, this category is considered to 
have an autoinflammatory origin rather than an autoimmune one. Patients 
with RF-positive polyarthritis represent 1-3% of all cases of JIA and are 
believed to be similar to those suffering from adult RF-positive RA (van 
Rossum et al. 2003). Enthesitis-related arthritis (ERA) is a form of 
undifferentiated spondyloarthropathy (SpA). (Colbert et al. 2010). In all 75-
80% of patients with ERA are HLA-B27 positive and the occurence of the 
antigen is one of the inclusion criteria for ERA. The category of oligoarthritis 
is the most common category of JIA, heterogeneous and well defined, which 
is only seen in children (Martini et al. 2003). There are two subcategories of 
oligoarthritis: a persistent form in which the disease affects four joints or 
fewer and an extended form in which more than four joints are affected after 
the first six months of disease (Petty et al. 2004). RF-negative polyarthritis is 
a heterogeneous group of JIA patients comprising patients with the 
involvement of five or more joints during the first six months of the disease 
but negative in RF. The occurrence of ANA, age at onset and remission 
status are very similar to the oligoarticular extended category. In adult 
rheumatology, it is well known that patients with psoriatic arthritis run the 
risk of developing sacroiliitis (McGonagle et al.  2005, McGonagle et al. 
2007). The ILAR criteria keep the juvenile psoriatic arthritis strictly apart 
from the ERA category. If a child with JIA develops signs of sacroiliitis, it 
can only be classified as ERA or as undifferentiated. The undifferentiated 
category is fairy common, approximately 14% in Swedish population-based 
studies. Many of these children have been excluded from the ERA category 
or fit into more than one category. This demonstrates a weakness of the ILAR 
criteria. The classification is under evaluation  (Nordal et al. 2011) and, as a 
result, the discussion George Still initiated in 1896 concerning the definition 
is ongoing even today. 
1.2. Clinical manifestations of JIA 
The vast majority of children with JIA have arthritis. The definition of 
arthritis by the ILAR is based on clinical findings of joint swelling or limited 
range of joint mobility with pain and tenderness. Any joint may be affected. 
The initial changes in a joint with arthritis take place in the synovial 
membrane. The immunological reaction with oedema and the accumulation 
of plasma cells, T- and B-lymphocytes and macrophages leads to the 
production of pro-inflammatory mediators, such as cytokines. The cytokines 
activate more inflammatory cells, the vascularity increases and there is an 
increase in the synovial layer thickness. The hyperplastic synovium changes 
Anna-Lena Cedströmer 
 5 
to villous hyperplasia termed “pannus”. The pannus infiltrates and erodes the 
articular cartilage and adjacent bone (Textbook of pediatric rheumatology 
2011). Enthesitis is defined as inflammation of the sites where the tendons, 
ligaments, capsules or fascia are attached to bone and it can be difficult to 
differentiate clinically from arthritis (Borman et al. 2006). Enthesitis is seen 
primarly in the JIA category of ERA. Other extra-articular manifestations that 
are common in JIA include uveitis, tenosynovitis, dactylitis and occasionally 
systemic involvement such as lymph node enlargement, hepato- and 
splenomegaly, serositis and fever. 
1.3. Treatment of JIA 
The management of JIA is based on a combination of pharmacological 
interventions, physical and occupational therapy, as well as psychosocial 
support. The pharmacological treatment of JIA is a challenge, because no 
single drug is able to cure the many variants of the disease. The treatment is 
mainly symptomatic, employing a multidisciplinary approach and is directed 
at minimising inflammation that causes joint damage, impaired growth and 
development, long-term disability and a secondary decrease in quality of life 
(Ravelli et al. 2007). Over the past few decades, new medical therapies have 
improved disease control (Textbook of pediatric rheumatology 2011). In the 
majority of patients, non-steroidal anti-inflammatory drugs (NSAIDs) are the 
mainstay of treatment, because they suppress the mediators of inflammation, 
reduce pain and improve mobility. Intra-articular corticosteroid injections 
prevent deformities and are commonly used (Lanni et al. 2011). Disease 
modifying anti-rheumatic drugs (DMARD) are the next choice and 
methotrexate (MTX) has been chosen most frequently since the first 
publication on its use in 1986, while the most effective dose was proposed in 
a randomised trial (Ruperto et al. 2011). New drugs that bind and inactivate 
the pro-inflammatory cytokine tumour necrosis factor alpha (TNFalpha), 
have led to important improvements in the management of JIA in recent 
years (Ravelli et al. 2007). Other so-called biological therapies have added 
further opportunities to modify the action of cytokines involved in the 
inflammatory process. Even though studies of medical therapies in JIA have 
increased, the basis for therapy largely relies on experience (Hashkes et al. 
2005). 
1.4. Disease activity 
Disease activity has been evaluated in different ways over time. According to 
the recommendations of the European League Against Rheumatism 
Juvenile idiopathic arthritis 
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(EULAR) (Andersson-Gäre et al. 1995), disease activity can be described as 
active disease (with an increased number of engaged joints), stable disease 
(where the engaged joints are unchanged), inactive disease (without treatment 
for less than two years) and remission (with no disease activity and no 
treatment for more than two years). In 1997, the core outcome variables 
(COVs) were published (Giannini et al. 1997), with a minimum level of 
improvement as a primary outcome in JIA (the ACR paediatric 30 response 
criteria). It requires an improvement of at least 30% from baseline in three of 
the six COVs, with no more than one of the six deteriorating by > 30%. In 
2004, an international consensus group developed preliminary criteria for 
inactive disease and clinical remission (Wallace et al. 2004). Nowadays, the 
term “minimal disease activity (MDA)” has come to the agenda. A 
preliminary definition of MDA was validated in 2008 (Magni-Manzoni et al. 
2008). 
1.5. Outcome of JIA 
In order to study the outcome of JIA, population-based studies are most 
relevent. In a long-term prospective study of JIA in a population-based 
Nordic setting, Nordal et al. (2011) found that ongoing disease was evident in 
58% of the children after eight years of disease.  Flato et al. (2003) conducted 
a prospective study on 316 patients with JIA. After a median of 14.9 years of 
disease duration, they found that the disease was in remission for half the 
patients, 24% had developed joint erosions and 36% had impaired physical 
function. Generally, patients with JIA had more disability, more bodily pain 
and poorer general health than the controls. In another study, an 11-year 
follow-up study of 26 patients, those with JIA with the oligoarticular 
persistent category had the best prognosis, while growth abnormalities and 
radiographic changes were more commonly found in those with polyarticular 
JIA and the systemic onset of disease (Narayanan et al. 2002) 
1.6. Temporomandibular disorders (TMD) in 
children and adolescents 
Temporomandibular disorders (TMD) represent a group of conditions 
characterised by pain and dysfunction in the TMJ and the surrounding tissues 
(Dworkin et al. 1992). Different indices have commonly been applied to 
summarise signs and symptoms from the orofacial area in epidemiological 
surveys. Helkimo’s dysfunction and anamnestic indices (Helkimo 1974) are 
indices that have been commonly used in epidemiological contexts (Carlsson 
et al. In: Temporomandibular joint and masticatory muscle disorders 1994) 
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among children and adolescents (Toscano et al. 2009). A widely accepted and 
used classification system is the Research Diagnostic Criteria for 
Temporomandibular Disorders (RDC/TMD) (Dworkin et al. 1992). This 
classification system included an Axis I physical assessment and an Axis II 
assessment of psychosocial status and pain-related disability. It remains a 
model for pain research and has now been replaced by the Diagnostic Criteria 
for Temporomandibular Disorders (DC/TMD) (2014) for both clinical use 
and research (Schiffman et al. 2014) Ranges of TMD pain vary in healthy 
individuals, from 8-15% for women and 3-10% for men, in population-based 
studies (Dao et al. 2000). In children before puberty, pain is rare (le Resche et 
al. 2007) 
1.7. Pain and jaw function in JIA 
To get the diagnosis of TMD according to Research Diagnostic Criteria, 
general joint disease must be lacking. It is, however, reported that children 
with JIA have dysfunction in the TMJ and can have symptoms and signs of 
TMD, such as clicking, regardless of their general joint disease. In the 
literature, there are vast discrepancies between reports on pain and 
dysfunction among patients with JIA. Pain from the jaws during function and 
rest may be severe in JIA, as well as limited opening capacity, joint sounds, 
locking and palpatory tenderness in the TMJ and associated muscles (Ringold 
et al. 2009). The prevalence of signs and symptoms in the masticatory system 
in patients with JIA has varied between 17%-87% in previous studies, 
(Billiau et al. 2007, Pedersen et al. 2001, Twilt et al. 2004), with large 
differences between previous subcategories. This disparity might be due to 
large variations in patient sample composition but also to the examination 
methods used. Furthermore, the number of examined subjects has often been 
limited. 
1.8. Temporomandibular joint involvement in 
JIA 
It has been suggested that the temporomandibular joint is one of the most 
frequently involved joints in JIA, according to radiographic changes (Ringold 
et al. 2009). Swelling is seldom seen and arthritis in the TMJ is often 
asymptomatic. As a result, the TMJ has been called “the forgotten joint” in 
paediatric rheumatology (Arabshani et al. 2006). The reported prevalence of 
TMJ involvement varies from 17% to 87% depending on the population 
investigated, the categories of JIA represented and the radiological method by 
which involvement is diagnosed (Kjellberg et al. 1998, Küseler et al. 1998, 
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Mayne et al. 1969, Mericle et al. 1996, Ronchezel et al. 1995). TMJ 
involvement is thought to occur during the active phase of JIA, when the 
inflammation generates chondral and subchondral bone lesions and the 
consequences for mandibular growth and development may be considerable, 
regardless of whether or not there are signs and symptoms (Kjellberg 1995 
a). TMJ arthritis might be present despite limited or otherwise quiescent 
disease and in the presence of concurrent systemic immunomodulatory 
therapy (Stoll 2012, Arabshahi et al. 2005). Subjective symptoms display a 
vast variation (Müller et al. 2009, Svensson et al. 2000, Twilt et al. 2004, 
Weiss et al. 2008, Olsson et al. 1991) 
1.9. Condylar growth of the TMJ in JIA 
The TMJ is unique because it presents with special features compared with 
other joints. The articular layer is composed of dense fibrous connective 
tissue rather than hyaline cartilage and the condylar growth is situated in 
close proximity to the articular surface and joint capsule rather than the 
growth plate, as in long bones. A disc is present for hinging and gliding 
movements and the two joints are connected and dependent on each other 
(Pirttiniemi et al. 2009). Arvidsson et al. (2009) suggest that condylar 
alterations in JIA may be caused by undergrowth, secondary to growth centre 
damage, or overgrowth, possibly related to inflammation-induced increased 
vascularisation and growth factor release. The result is a deformed joint due 
to remodelling (Arvidsson et al. 2009, Arvidsson et al. 2010). 
1.10. Imaging of the temporomandibular joint 
As involvements of the TMJs are often asymptomatic, imaging examination 
appears to be important to evaluate JIA involvement in this particular joint 
(Twilt et al. 2008). Different imaging methods for the TMJ exist. In the last 
few decades, magnetic resonance imaging (MRI) has become the golden 
standard for examining the TMJs in children with JIA , as it has been found 
to be an efficient method for detecting early inflammatory changes (Küseler 
et al. 1998, Weiss et al. 2008, Cannizzaro et al. 2011). On MRI, it is possible 
to detect ongoing inflammation (Weiss et al. 2008). Computed tomography 
(CT) is also a widespread technique and it is often used in this context (Hu et 
al. 1996, Arvidsson et al. 2010). Arvidsson et al. (2010) found that 70% of 
JIA patients had TMJ involvement on CT and MRI. MRI and CT are 
demanding, expensive examinations. In contrast, panoramic radiography is 
simple, inexpensive, with relatively low radiation doses (Cohnen et al. 2002), 
commonly available and requires no sedation in young children. On 
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panoramic radiographs, it is only possible to see old damage and changes on 
the skeleton. It is often performed prior to MRI or CT examinations in 
clinical practice. Previous studies have found condylar lesions on panoramic 
radiographs in 17-78% of patients with JIA (Rönning et al. 1974, Pedersen et 
al. 2001, Twilt et al. 2004, Billiau et al. 2007, Arvidsson et al. 2009). There is 
thus a substantial spread in the results relating to the prevalence of condylar 
lesions among patients with JIA, even when the same radiological technique 
has been used. 
1.11. Facial growth in JIA 
TMJ involvement has been regarded as the most important cause of changed 
facial growth (Kjellberg et al. 1998). The condyle can grow to the third 
decade (Pirttiniemi et al. 2009), as different from the suture of the maxilla, 
which is almost completed at 10 years of age (Irie et al. 1975). If the condylar 
growth is inhibited, the lower jaw rotates backwards in relation to the cranial 
base, giving a steeper mandibular plane angle and a shorter posterior facial 
height (Kjellberg et al. 1995 b, Kjellberg et al. 1995 c). The result is a more 
convex profile and reduced mandibular protrusion. Asymmetries can emerge 
if the condyles are differently affected. Structural changes seen 
radiographically can recover and normalise in cases with low disease activity 
(Arvidsson et al.  2010, Twilt et al. 2009). 
1.12. Long-term effects of JIA on jaw function 
Few studies have been published on the long-term effects of JIA on jaw 
function and all are referral based. Follow-up studies have shown the 
progression of the disease in the TMJs; new abnormalities or the progression 
of existing abnormalities (Rönning et al. 1981, Pedersen et al. 2008, Mussler 
et al. 2010). Moreover, improvement in the condylar alterations including 
normalisation with panoramic radiography, has been reported (Twilt et al. 
2007, Twilt et al. 2008). 
1.13. Outcome of JIA in the jaw system 
Little is known about the outcome of JIA in the TMJs. Earlier studies have 
often covered a limited number of patients and have not always used the 
ILAR criteria for classification. In addition, the introduction of new medical 
therapies might have changed the prognosis for JIA in the jaw system. Our 
intention was to evaluate how signs and symptoms of the orofacial region, 
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disease activity and medication over time were associated with condylar 
alterations on panoramic radiographs in children with JIA.  
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2 AIM 
The overall aim was to investigate how JIA manifests in the jaws.  
Specific aims: 
1. To evaluate the development of symptoms from the 
orofacial region over time in a cohort of patients with JIA 
compared with a cohort of matched healthy control patients 
2. To describe systematically the clinical and subjective 
involvement of the TMJ and associated structures in 
children diagnosed with JIA and relate the findings to 
disease activity and TMJ condylar alterations, as assessed on 
panoramic radiographs 
3. To evaluate how longitudinal medical treatment of JIA and 
the burden of disease activity influence the development of 
TMJ condylar alterations as assessed on panoramic 
radiographs 
4. To investigate on cephalometric radiographs the facial 
morphology of children with JIA and relate the findings to 
disease activity over time and to TMJ condylar alterations 
assessed on panoramic radiographs 
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3 PATIENTS AND METHODS 
3.1 Study I 
3.1.1 Study population 
 
Figure 1. The original cohort and the follow-up cohort of patients with JIA and 
gender- and age-matched control group 
 
The original cohort comprised 40 patients, 28 girls and 12 boys, who were 
referred from the Department of Paediatrics and Rheumatology at the 
University Hospital in Umeå, Sweden. The inclusion criteria were arthritis 
for at least three months before 16 years of age. Patients with psoriatic 
arthritis were excluded. The mean age at the original examination was 18 
years. The age of onset ranged from one to 14 years and the duration of the 
disease varied from eight to 24 years. Sixteen had a clinical disease profile 
like polyarticular and 24 belonged to the oligoarticular category. The control 
group, n=40, was matched in terms of age and gender. The control sample 
had not been diagnosed with general joint disease and the patients’ closest 
relatives were also free of joint disease.  
80	  individuals
40	  patients	  (28	  girls	  
12	  boys)	  40	  controls	  	  
(28	  girls	  12	  boys)
15-­‐year	  
follow-­‐up
70	  individuals
36	  patients	  (24	  
women	  12	  men)	  34	  
controls	  (22	  women	  
12	  men)
2	  deceased 8	  unidentified
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At the 15-year follow-up, the study comprised 70 individuals, 36 with JIA, 
24 women and 12 men, and 34 from the control sample, 22 women and 12 
men. Two had died and the addresses for eight subjects could not be found. 
The study consisted of a questionnaire in which the first part included the 
subjects’ estimation of their own general health (good, neither good nor bad, 
bad), intake of medication and chewing ability. The second part of the 
questionnaire related to wether the subjects had any jaw-related symptoms 
(pain at rest and function, difficulty opening the mouth wide, 
stiffness/fatigue, TMJ sounds, headaches and neck and shoulder pain). To 
determine the frequency of jaw-related symptoms, they were evaluated, using 
5 alternatives: never, once/twice a month, once a week, several times a week 
and daily. Helkimo’s anamnestic index (Ai) was calculated to define the 
severity of the symptoms. The third part included questions relating to 
awareness of different parafunctions, type of joint disease, employment, 
quality of life, impairment of daily life (ability to do housework unhindered, 
to move/walk freely and whether their quality of sleep was good) and 
utilisation of health care owing to TMD (surgery, steroid therapy, 
acupuncture, heat, analgesics, occlusal adjustments, splint, transcutaneous 
electrical nerve stimulation, massage). 
3.2 Studies   II-IV  
3.2.1 Study population  
All patients who fulfilled the ILAR criteria for JIA (Petty et al. 2004) and 
who were referred to one of three specialist dental clinics in Sweden 
(Department of Surgical Sciences, Oral and Maxillofacial Surgery in 
Uppsala, the Orofacial Pain Specialist Clinic in Gothenburg and the 
Department of Clinical Oral Physiology at the Eastman Institute in 
Stockholm) over an eight-year period (between 1 January 1999 and 31 
December 2006) were included. Eligible patients had to be born after 1 
January 1986, as they were covered by free dental care and therefore more 
likely to come to an examination. 
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Figure 2. The 266 JIA patients included in Study 2 
Figure 3. The JIA patients included in Study 3 
Figure 4. The JIA patients included inStudy 4 
278	  referred	  
children
266	  included	  in	  the	  
study
12	  without	  JIA	  
diagnosis
266	  referred	  
children
184	  with	  	  panoramic	  
radiography
82	  without	  	  panoramic	  
radiography
21	  had	  no	  medical	  data	  at	  the	  
time	  of	  the	  panoramic	  
radiographs
5	  panoramic	  radiograph	  
unreadable
158	  included	  in	  the	  
study
266	  referred	  
children
75	  had	  
cephalometric	  
radiograph
2	  without	  	  panoramic	  
radiography
8	  panoramic	  radiograph	  
unreadable
65	  included	  in	  the	  
study
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Method 
3.2.2 Study II  
A specialist dentist made a clinical assessment, according to structured 
protocols, of orofacial signs at the study visit. Anamnestic information 
related to patient-reported symptoms was collected using standardised 
questions to the patient and/or parents/carers on the same occasion. The 
evaluations by the specialist dentists were read retrospectively and Helkimo’s 
indices (Helkimo 1974) were calculated. Helkimo’s clinical dysfunction 
index, Di 0-III, evaluates mandibular mobility, TMJ function, muscle pain, 
TMJ pain and pain on movement of the mandible on a three-point scale of 
increasing severity; 0, 1 or 5. The sum, 0-25 points, constitutes the 
dysfunction score, which forms the basis of the clinical dysfunction index. 
The signs found at the clinical examination can thus be expressed as Di 0 (0 
points, no signs), Di I (1-4 points, mild signs), Di II (5-9 points, moderate 
signs), or Di III (10-25 points, severe signs). Helkimo’s anamnestic index, Ai 
0-II, summarises TMJ sounds, fatigue/stiffness of the jaw, pain, difficulty 
moving the jaw, locking and luxation. Ai 0 denotes the complete absence of 
subjective symptoms, Ai I denotes mild symptoms, such as joint sounds, 
stiffness or fatigue of the jaws, Ai II denotes severe symptoms, with one or 
more of the following reported in the anamnesis: difficulty opening the 
mouth wide, locking, luxation or pain on movement, facial and jaw pain. 
Data from medical records at the paediatric rheumatology clinics where the 
participating patients were treated were collected and interpreted under the 
supervision of one paediatric rheumatologist. General disease activity during 
the last two years before the study visit was recorded.  
Table 2. A modified version of the European League Against Rheumatism 
(EULAR) criteria, as presented by Andersson-Gäre (Andersson Gäre 1995), 
was used with the addition of one further category (five categories). 
EU Disease activity according to EULAR 
1 Active disease (increasing number of engaged joints) 
2 Stable (unchanged number of engaged joints) 
3 Inactive with treatment (no disease activity) 
4 Inactive without treatment (no disease activity and no treatment for less than two years) 
5 Remission (no disease activity and no treatment for more than two years). 
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Presence/absence of condylar alterations, morphological (flattening, 
osteophyte) or structural (erosion, sclerosis, subchondral cysts), was 
evaluated on panoramic radiographs. The dichotomous assessment, alteration 
/no alteration, was made by one dentist, together with an oral radiology 
specialist, until consensus was reached; all on one occasion. Both were 
blinded to all other dental and medical information. 
3.2.3 Study III 
Evaluations of the TMJs on panoramic radiographs were made as in Study II. 
The latest panoramic examination was used for analysis. Seventy-two 
patients had only one panoramic radiograph performed. Moreover, any 
toadstool appearance of the condyles, as described by Petrovski et al. (2009), 
was registered separately. In this condition the condyle is flattened, elongated 
and dorsally inclined. The condylar neck is shortened or absent.  
If one or both condyles were judged as “unreadable”, the individual was 
excluded. Eighty-six percent of the radiographs were digital and analysed on 
monitors, while analogous radiographs were analysed in an X-ray light box. 
Fifty randomly selected cases were evaluated until consensus was reached a 
second time after three weeks, in order to establish the reliability of the 
evaluation over time. 
The total pharmacological treatment was evaluated longitudinally from 
disease onset, established by the rheumatologist, to the time of the panoramic 
examination. Medication with DMARDs, which included MTX, and/or 
biologically modifying medications, including tumour necrosis factor alpha 
inhibitors (TNF-alpha) and/or corticosteroid injections in the TMJ, was 
denoted “potent medication”. The use of “potent medication” for six months 
or more was denoted a “medication period”. An evaluation of medical 
treatment was performed for each six-month period during the first year after 
onset and then once every year until panoramic examination. A shorter period 
than six months of “potent medication” or patients only using non-steroidal 
anti-inflammatory drugs (NSAID) were not included. 
The disease activity groups were the same as in Study II, except that activity 
was evaluated longitudinally from disease onset to the time of the panoramic 
examination and not only the last two years. Disease activity, defined as EU 
1 and/or 2 for six months or more, was denoted “active disease”. The first 
year after onset was evaluated for each six-month period and thereafter once 
every year. The time from disease onset to the date of the radiological 
examination could thus be described as the number of “medication periods” 
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and “active disease periods”. The number of “medication periods” and 
“active disease periods” varied from 0 to 8 and patients were followed for 
seven years at most. 
3.2.4 Study IV 
At least one cephalometric radiograph had to be performed during the study 
period to be included in this study. Seventy-five patients of the 266 
previously included had a cephalometric radiograph performed. Eight were 
judged as unreadable and two patients had no panoramic radiograph to 
compare with and as a result, 65 patients were included, 50 girls (77%) and 
15 boys (23%). Their median age was 12.0 years. 
The facial morphology evaluated on the cephalometric radiograph was 
compared with condylar alterations on panoramic radiographs that were 
performed approximately the same year as the cephalometric radiograph. The 
evaluations of the TMJs on the panoramic radiographs were performed as 
previously described. 
 
 
Figure 5. Reference points and lines used in the cephalometric analysis. 
Reference points: A (subspinale, the deepest point in the concavity of the anterior 
maxilla between the anterior nasal spine and the alveolar crest), ANS (anterior 
NSL 
NL 
ML 
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nasal spine, the tip of the anterior nasal spine), B (supramentale, the deepest 
point in the concavity of the anterior mandible between the alveolar crest and 
pogonion), Ba (basion, the most inferior point on the anterior margin of the 
foramen magnum, Gn (gnathion, the most antero-inferior point on the bony chin), 
Go (gonion, a mid-planed point at the gonial angle of the mandible located by 
bisecting the posterior and inferior borders of the mandible), Me (menton, the 
lowest point on the lower border of the mandibular symphysis, N (nasion, the 
junction of the frontal and nasal bones at the naso-frontal suture), Pg (pogonion, 
the most anterior point on the mandibular symphysis), PNS (the tip of the 
posterior nasal spine), S (sella, the centre of the sella turcica), ),  Ii (the incisal tip 
of the lower central incisor) Is (the incisal tip of the upper central incisor), Ili (the 
incision line inferius), Ils (the incision line superius). 
Reference lines: NSL (nasion-sella line, the line through points N and S) NL 
(nasal line, the line through points ANS and PNS), ML (mandibular line, the 
tangent to the lower border of the mandible through M and Go). 
 
The cephalometric radiographs were performed under standardised 
conditions with a natural head position and the teeth in centric occlusion. The 
lateral cephalometric radiographs were analysed using the FACAD 3.0 
software cephalometric tracing program. Cephalometric measurements were 
carried out using conventional reference points and reference lines, see 
Figure 5. The analysis included antero-posterior skeletal relationships, 
including maxillary protrusion (SNA), mandibular protrusion (SNB) and the 
sagittal jaw relationship (ANB). The vertical skeletal relationship included 
mandibular angulation (ML/NSL), maxillary angulation (NL/NSL), the 
vertical jaw relationship (ML/NL) and the relationship between the upper and 
lower facial height (U/L FH). 
To establish the intra-examiner reproducibility, sixteen randomly selected 
cases were evaluated a second time, approximately two months apart. The 
intraclass correlation (ICC) was calculated according to Shrout and Fleiss 
(1979). The differences between the two measurements were compared. No 
significant differences between duplicate recordings were identified. 
3.3 Statistics  
All statistical analyses were performed using SPSS. A 5% significance level 
was used throughout, unless otherwise stated. Study I: to test for differences 
in the distribution of symptoms general health and disability, the X2 test was 
used. If the expected count on one or more cells was less than 5, the Fisher’s 
exact test was used after transferring data to 2 x 2 tables. 
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Studies II, III: for comparisons of Di, Ai and EU between study clinics and 
all eight categories, the Kruskal-Wallis test was used. In order to test the 
difference between every two categories, clinical and radiographic, and to 
test the difference between condylar alterations or not the Mantel-Haenszel 
chi-square test was used. For comparisons of gender and age between all 
sites, the Pearson chi-square test and the Kruskal-Wallis test respectively 
were used. For comparisons between every two categories of gender and age, 
condylar alterations or not, Fisher’s exact test and the Mann-Whitney U-test 
respectively were used. Spearman’s rank correlation was used for the 
correlation analysis. Kappa statistics were used to evaluate reliability over 
time for condylar alterations. Bivariate logistic regression analysis was used 
to establish the risk of condylar alterations.  
Study IV: for descriptive purpose the median, the 25th and 75th percentiles 
were given for age at onset and at cephalometric radiograph and disease 
duration. Cephalometric tracings were presented with the mean and standard 
deviation (SD). Categorical variables were presented with number (n) and 
percent (%). In order to test the difference between condylar alterations, 
Fisher’s exact test was used for dichotomous variables and the Mann-
Whitney U-test for continuous variables. Univariate linear regression was 
used to evaluate cephalometric tracings related to the number of ”active 
disease periods”. Two-tailed statistical analyses were performed at a 
significance level of 5% (p<0.05) 
3.4 Legal and ethical aspects  
Study I has no ethical application. It was intended as an examination project 
that did not require ethical application. Due to interesting results, the study 
expanded into a full article. The journal did not demand an ethical application 
for publication. In a later inquiry, members of the ethical committee found 
that an ethical application in hindsight was not possible. 
The multicentre studies (study II-IV) was approved by the Ethical Committee 
at the University of Gothenburg, Göteborg, Sweden (342-07). 
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4 RESULTS 
4.1 Study I 
Both the controls and the patients with JIA had more symptoms from the 
orofacial region at the follow-up after 15 years compared with the 
examination at baseline. A larger proportion of the JIA sample had an 
anamnestic dysfunction index of II compared with the control group. The 
prevalence of signs in the craniofacial region was higher at the follow-up 
examination compared with baseline data among both cases and controls. 
TMJ clicking sounds were the most commonly reported symptom among 
both cases and controls. At the 15-year follow-up, patients with JIA reported 
a statistically significantly higher prevalence of jaw and facial pain, impaired 
maximum jaw-opening capacity and feelings of tiredness in the jaws 
compared with controls. The patients with JIA were more aware of 
toothclenching and grinding habits at both examinations, but the difference 
only reached a significant level for tooth-clenching at the follow-up 
examination. The prevalence of headaches and neck pain increased three and 
five times in the JIA group from 1986 to 2001. Cases that reported frequent 
pain in the jaws and/or pain on jaw movements reported frequent pain in the 
neck/shoulder region. 
Nine individuals (32%) in the JIA group reported that they had no ongoing 
joint disease at the follow-up study. The JIA group had significantly more 
difficulty to performing housework and an impaired ability to move freely 
compared with the control group. 
Almost a third of the JIA sample had consulted a dentist because of TMD 
symptoms compared with 8% of the controls.  
4.2 Study II 
When it came to gender, age at disease onset or at examination or frequency 
of Di and Ai among the included patients, no differences were found between 
the study centres. The specialist dental clinic in Gothenburg had most 
patients with extended oligoarthritis while Stockholm and Uppsala had most 
patients with persistent oligoarthritis. Patients at the specialist dental clinic in 
Gothenburg had most active disease, EU 1. The clinic in Gothenburg 
performed fewer radiological examinations than the clinics in Uppsala and 
Stockholm. 
Anna-Lena Cedströmer 
 21 
The specialist dental examination was performed at a mean of 2.9 years after 
disease onset. Clinical signs in the patients, Di I-III (mild, moderate or 
severe), were found in 57.7% to 92.0% in the different ILAR categories, 
while subjective symptoms in the patients, Ai I-II (mild or severe), were 
found in 32.0% to 76.0%. There were significant differences between the JIA 
categories in both Di and Ai. The psoriatic category had most orofacial signs 
and symptoms, according to Helkimo’s indices, while patients diagnosed 
with persistent oligoarthritis had the fewest. There was a correlation between 
Ai and Di. Seventy-six per cent had a disease activity of 1 or 2. Patients with 
systemic arthritis had most disease activity, EU 1. Severe disease activity, 
(EU 1 and EU 2) was associated with clinical signs, Di, and subjective 
symptoms, Ai.  
A panoramic examination was performed in 134 patients at the study visit. 
No differences in the proportion of radiological examinations between 
categories, gender, age at onset or age at examination, Di or Ai, was found. In 
patients with disease activity EU 2, radiological examinations were 
performed more frequently. Four of the panoramic radiographs were judged 
as “unreadable”. Of the remaining radiographs in 130 patients, 48 (37.0%) 
were rated as having a condylar alteration. No significant association between 
condylar alterations and category, gender, age at onset, age at examination, 
clinical signs (Di), subjective symptoms (Ai) or disease activity was 
observed.  
4.3 Study III 
Of the total of 266 patients with JIA, panoramic radiographs were exposed in 
184 patients, 69% during the eight-year study. Medical data from the same 
year as the panoramic examination were found in 163. Five radiographs were 
judged as “unreadable” and 158 patients were finally included. The median 
disesase duration was 2.5 years. Five patients had missing medical data for 
one or two periods between onset and the panoramic examination. The 
reliability of the dichotomous radiological assessments (structural and/or 
shape alteration or not) over time was kappa = 0.68 (95% CI 0.56 to 0.80). 
This strength of agreement is considered to be substantial (Landis et al. 
1977). 
Condylar alterations on panoramic radiographs were found in 68 patients 
(43%) and were not significantly associated with ILAR category, gender and 
age at onset or duration of disease. Sixty-seven patients had shape alterations, 
25 structural alterations and 12 toadstool appearances. Eight of these also had 
condylar alterations. 
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Patients with any “potent medication”, increased numbers of “medication 
periods”, patients with “EU 1 or potent medication” and “EU 1 and potent 
medication” ran an increased risk of condylar alterations. The risk of 
condylar alterations with a larger number of “active disease periods” was not 
statistically significant, only close to it (p = 0.06). There was a significant 
positive correlation between EU 1 and “potent medication”. 
4.4 Study IV 
Condylar alterations were found in 38 patients (58%) of the 65. All 38 had 
structural changes and 15 had shape alterations. As a reference, the 
cephalometric standards of healthy Swedish children reported by Thilander et 
al. in 2005 were used. The whole group of children with JIA had a more 
retrognathic mandible (SNB, ANB) and a steeper mandibular plane 
(ML/NSL, ML/NL) compared with the reference group. A statistically 
significant difference between children with and without condylar alterations 
was found. Children with condylar alterations had a more retrognathic 
mandible (SNB, p=0.04), SnPog, p=0.02) and a steeper mandibular plane 
(ML/NSL, p=0.01, NL/NSL, p=0.03).  
The number of “active disease periods” varied between 0 and 15. The median 
number of “active disease periods” was 3.0 in the total group of 65 children. 
A univariate linear regression analysis revealed that the number of “active 
disease periods” was not associated with any of the 12 cephalometric 
variables, but the study cohort was small. 
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5 DISCUSSION 
5.1 Methodological aspects 
5.1.1 Study design 
The first study was a longitudinal follow-up of adult patients with previously 
diagnosed JIA and symptoms from the orofacial region. Moreover their 
general health, type of joint disease, utilisation of health care, employment, 
quality of life and impairment of daily life, were compared with a control 
group matched in terms of age and gender. One of the risks in follow-up 
studies is a loss of a significant number of patients. In our study, 10 patients 
dropped out (13%) due to death and unobtainable addresses. Fifty-four 
returned the questionnaire, but, considering that it was 15 years between the 
two examinations, a response rate of 68% is acceptable. The design of 
Studies II-IV was suitable for analysing TMJ arthritis, craniofacial growth 
and disease activity over time. One strength of the studies was the fairly large 
cohort, in contrast with many previously described case series, with both 
objective and subjective variables involved and with radiological findings 
and cephalometric analyses as an end point. The percentage of all patients 
diagnosed with JIA that were referred to specialist dental clinics is not known 
and the number of patients in some of the ILAR categories was small, which 
weakens the results. The observational design also implies that the impact on 
the condyles in the event of no medication in active disease is unknown. 
5.2 Imaging 
Panoramic radiography has limited diagnostic value for TMJ, as it only 
provides an overview of the jaws and only large condylar changes can be 
evaluated with any confidence. The method has acceptable reliability and 
specificity but low sensitivity, compared with more advanced radiological 
techniques, such as MRI, CT or Cone Beam Computed Tomography 
(CBCT). Compared with adults, children have smaller, rounder condyles. As 
a result, the influence of the long-axis angulation of the condyle on the 
radiographic anatomy is less pronounced, making it easier to detect 
pathological condylar deformations in children (Arvidsson et al. 2009). 
Panoramic examinations are simple, inexpensive and easily accessible at 
most clinics, involve low radiation levels and require no sedation in young 
children. Different scoring systems for lesions on the condyles have been 
applied (Twilt et al. 2004, Twilt et al. 2008, Billiau et al. 2007, Pedersen et 
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al. 2001, Arvidsson et al. 2009). To simplify the categorisation, condylar 
alterations were only registered dichotomously in this study. 
5.3 Clinical examination 
In Studies II-IV, one dentist summarised all the standardised clinical and 
anamnestic protocols. A group of experienced but not calibrated examiners 
were involved in the original data collection. This implies a weakness, in 
terms of both validity and reliability. Some differences in patient 
characteristics between the sites were observed, partly reflecting variations in 
clinical routines. 
5.4 General discussion 
Study I indicates that the prevalence of pain and dysfunction in the orofacial 
area increases from childhood to adulthood and increases among the patients 
with JIA more than among healthy controls. The finding that one third of the 
JIA patients had seen a dentist due to their symptoms indicates that a 
considerable number of their symptoms are located in the orofacial area. This 
suggests a higher risk of pain and dysfunction among patients with JIA. Few 
JIA patients reported impaired general health when they were children. In 
2005, Sawyer et al. reported that children with JIA reported less impaired 
general health than their parents. The relationship between impaired jaw-
opening ability and neck/shoulder symptoms is interesting. Patients with JIA 
can develop severe damage of the TMJ (Rönning et al. 1974, Hu et al. 1995, 
Pedersen et al. 2001, Twilt et al. 2004, Billiau et al. 2007, Arvidsson et al. 
2009). Zafar et al. (2000) have shown that the jaw and the neck interact 
during jaw-opening.  
Studies II-IV comprise patients with JIA but no healthy control group. 
Studies indicate that recurrent pain in children and adolescents is common.  
About 400,000 children in Sweden (20%) have pain in the head, stomach or 
back once a week (Alfvén et al. 2012).  In a study of schoolchildren, 1/3 
reported weekly pain. Impaired health-related quality of life (HRQoL) was 
twice as common in children with recurrent pain compared with children 
without pain (Petersen et al. 2009).  
The study design we have used was unfortunately unable to evaluate quality 
of life in children with JIA. Different methods to measuring health status are 
critical when it comes to understanding the health status of children with JIA, 
for making decisions in clinical practice and for evaluating and comparing 
the effect of therapies in clinical research studies. The Pediatric Quality of 
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Life Inventory (PedsQL) is a well-validated, reliable and sensitive measure of 
HR-QOL in children with chronic disease (Varni et al. 2002, Varni et al. 
2003). Disability and pain have been found to be the most important 
determinants of physical and psychosocial well-being, in a European and 
Latin American study of HRQOL in JIA patients (Gutiérrez-Suárez et al. 
2007). In a Swedish cross-sectional study and a Swedish prospective 
longitudinal population-based study, children with JIA experienced reduced 
quality of life (Lundberg et al. 2012, Nordal et al. 2011). Measurements of 
health-related outcomes need to be evaluated for JIA to generate new 
therapies and to meet the expectations of patients and families with JIA 
(Ringold et al. 2007). Well-being in the temporomandibular joints is an 
important goal for many children.  
Different methods for collecting data on temporomandibular signs and 
symptoms have been used over the years. Helkimo’s clinical dysfunction 
index, Di, and anamnestic dysfunction index, Ai, are coarse quantifications of 
signs and symptoms in the orofacial area, but the standardised evaluations 
facilitate comparisons between patients and conditions. The indices have 
acceptable levels of reproducibility, not only for the same observer but also 
between different observers (Helkimo 1974, Magnusson et al. 1985) and are 
strongly correlated with other indices (Schiffman et al. 1992). Di and Ai have 
been widely used in epidemiological contexts relating to temporomandibular 
disorders (TMDs) (Carlsson et al. In: Temporomandibular joint and 
masticatory disorders 1994), also among children and adolescents (Toscano 
et al. 2009). TMDs with signs and symptoms similar to those in JIA also 
occur in the healthy, general population. Signs and symptoms have been 
found to be less frequent in children than in adults in general (Carlsson et al. 
In: Temporomandibular joint and masticatory disorders 1994). In a three-year 
longitudinal study of 12- to 19-year-olds in a Swedish county, the incidence 
of TMD pain was 2.9% and 11.4% reported TMD pain on at least one 
occasion. The pattern of TMD pain fluctuated and was more common in girls 
(Nilsson et al. 2007). In a cross-sectional epidemiological investigation 
covering two decades and involving about 100 children and adolescents aged 
3, 5, 10 and 15 TMD-related symptoms were very rare in 3- and 5-year-olds. 
Among 10- and 15-year-olds, 5-9% reported severe symptoms and up to 50% 
showed one or more TMD signs (Köhler et al. 2009). Longitudinal studies 
covering a long time period would provide more detailed information about 
the natural variation in TMD over time.  
Most of the 266 patients with JIA in our study cohort were afflicted in the 
orofacial area. Cases with severe dysfunction, Di III, were found in all but 
one of the diagnostic categories. Severe symptoms, Ai II, were found in all 
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categories. Orofacial engagement in young JIA patients, as found in this 
study, thus exceeds that in comparable, healthy groups. Severe signs and 
symptoms among JIA patients, according to Helkimo’s indices, have 
previously been presented, but all the ILAR categories were not represented 
(Savioli et al. 2004). 
The distribution of clinical signs and orofacial discomfort among the 266 
patients in Study II differed between the ILAR categories, where the psoriatic 
arthritis category had more clinical signs and symptoms than the other 
categories, despite similar disease activity. Previous studies have also found 
differences between categories, but the results vary. Pedersen et al. (2001) 
found most TMJ involvement in the polyarticular category, Twilt et al. 
(2004) in the systemic category and Cannizzaro et al. (2011) in the extended 
oligoarticular category. In our cohort, we found most symptoms and signs in 
the psoriatic category. One reason why the psoriatic arthritis category was 
more affected may be that psoriatic arthritis involves the synovium but also 
the surrounding tissues, the cartilage and the bone (Mc Gonagne et al. 2005, 
Mc Gonagle et al. 2007, Haroon et al. 2012). In our study, the RF-positive 
category had very few patients without any orofacial signs. It is known that 
the RF factor contributes to joint involvement (Pedersen et al. 2001, Twilt et 
al. 2004, Bas et al. 2003, Karhulahti et al. 1993), but, as the number of 
patients in this category was limited, it is difficult to draw confident 
conclusions. 
We concluded that there are associations between orofacial signs and 
symptoms and overall disease activity, assessed for two years. The findings 
were perhaps not unexpected, as the TMJ is one joint among others and high 
disease activity affects both articular and peri-articular structures. TMJ 
arthritis in JIA is often asymptomatic. Its unique anatomy and biochemical 
composition makes the TMJ susceptible to damage from arthritis (Ringold et 
al. 2009). Inflammation from the prenatal period to puberty can damage the 
growth center at the condylar head and results in alterations in mandibular 
growth (Ronchezel et al. 1995). The TMJ is also one of the most used 
synovial joints, with its frequent chewing and speaking, which makes it 
important to recognise and treat TMJ arthritis during childhood. 
In Study III, the radiographically examined group comprised 69% of the total 
cohort of 266 patients. Radiographic condylar alterations were found in 43% 
of the examined patients after a median disease duration of 2.5 years. Studies 
using the panoramic radiographic technique have reported different results in 
terms of TMJ condylar alterations, 17-78%, and the size of the studied 
populations has also varied from 97 to 249 JIA patients (Rönning et al. 1974, 
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Pedersen et al. 2001, Twilt et al. 2004, Billiau et al. 2007, Arvidsson et al. 
2009). The divergent results for condylar alterations are most probably due to 
different scoring systems and different patient populations. Condylar 
alterations, as judged on panoramic radiographs, were more common in 
patients with a heavier burden of longitudinal medication and consequently 
more severe illness. The fact that not all the patients were examined with 
panoramic radiography, together with missing medical data for solitary 
periods for some patients, entails a possible bias. 
Several authors have studied the importance of longitudinal medication for 
avoiding TMJ arthritis in JIA, as judged on panoramic radiography, with 
different results. Arvidsson et al. (2009) found no significant difference in 
TMJ abnormalities between patients with or without previous MTX treatment 
and/or the use of biological drugs studied for a mean duration of 3.2 years. 
Twilt et al. (2004) found TMJ involvement in 68% of the patients with 
previous or present DMARD (not MTX) as compared to 29% of patients with 
previous or present immunosuppressive therapy (corticosteroids and MTX) 
with a mean duration of 4.9 years. The difference between the groups was not 
discussed in more detail. Ince et al. (2000), on the other hand, found 
significantly more frequent and more severe condylar involvement in JIA 
patients without MTX at the time of the panoramic examination. The 
observation period was eight years for the non-MTX group and 6.9 years for 
the MTX group. It was concluded that MTX therapy may minimise the TMJ 
destruction, but longitudinal studies would provide more definitive 
information.  
The optimal therapy for avoiding TMJ arthritis has not yet been confirmed. 
TNF-alpha inhibitors are supposed to inhibit inflammation more effectively 
than MTX. Studies comparing TNF-alpha with or without MTX in terms of 
arthritis in the TMJ have not been performed. The new biological agents are 
used in approximately 20-25% of children with JIA in Sweden (Kazamia et 
al. 2014). A review concluded that some children with JIA develop TMJ 
arthritis despite TNF-alpha inhibitors (Ringold et al. 2009). In another review 
of randomised controlled trials in JIA on treatment with biological agents no 
conclusions about efficacy could be drawn, because of the small number of 
patients and differences in design between the trials (Otten et al. 2013). In our 
cohort of 266 children with JIA, some patients had TNF-alpha inhibitors for 
only a short period and it is therefore difficult to draw any conclusions about 
their effect on TMJ arthritis.  
Corticosteroid injections in the TMJ are effective for treating TMJ arthritis 
(Stoll et al. 2012), but this therapy alone was very uncommon in our study 
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cohort. Corticosteroid injections are also used to reduce disease activity in 
other joints in the body. 
A modified version of the EULAR was used to describe disease activity in 
this study, but there are other ways of categorising it. One limitation of 
EULAR is that the disease activity is only measured on active joints 
compared, for example, with JADAS 27, where the sums of components are 
compounded (McErlane et al. 2013). 
Several systems for describing disease activity in JIA have been developed.  
For studies of the effect of medical therapies, core outcome variables 
(COVs)(Giannini et al. 1997) were developed. Improvement as a primary 
outcome in JIA (the ACR paediatric 30 response criteria) requires an 
improvement from baseline of at least 30% in three of the six COVs, with no 
more than one of the six deteriorating by > 30%. As the care of children with 
JIA has advanced (Beresford et al. 2009), the minimum acceptable level of 
improvement has increased accordingly, with improvements of 50%, 70%, 
90% and even 100% (ACR Pedi50, Pedi70, Pedi90 and Pedi100). In 2004, an 
international consensus group drew up preliminary criteria for inactive 
disease and clinical remission (Wallace et al. 2004). Nowadays, the term 
“minimal disease activity (MDA)” has been added to the agenda, as it is a 
more realistic goal than remission. A preliminary definition of MDA was 
validated in 2008 (Magni-Manzoni et al. 2008) and identifies an intermediate 
state between active disease and remission.  This can be a useful treatment 
target in future observational studies and clinical trials in patients with JIA. 
MDA could be defined as a physician global assessment of < 2.5 cm and a 
swollen joint count of 0 in patients with oligoarthritis and a physician global 
assessment of < 3.4 cm, a parent global assessment of < 2.1 cm and a swollen 
joint count of < 1 in patients with polyarthritis. The effect of early aggressive 
therapy on the course of the disease has not been studied. The long-term 
effects of methotrexate and biological medication on remission, radiological 
changes, functional capabilities and the long-term adverse effects were 
previously unknown (Hashkes et al. 2005). Today, there are a multitude of 
treatment options, which have allowed children with arthritis to experience 
normal growth and development. As more is learned about the 
aetiopathogenesis of the different categories of JIA, it may become easier to 
target the right drug at the right child. It is clear that most children with non-
systemic JIA respond well to TNF-alpha inhibitors and MTX (Stoll et al. 
2014). 
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It is more difficult to diagnose disease activity in the TMJs compared with 
more easily examined joints like the knee joints. The activity indices that are 
available should pay more attention to the variables of the TMJ. The Juvenile 
Arthritis Damage Index (JADI) has a scale on articular damage from 0 to 72 
in which 0 = no damage and 72 = maximum damage. Unfortunately this 
index only counts severe lesions on the TMJs.  
According to Wahezi et al. (2013), there have been rapid therapeutic 
advances in the treatment of JIA and they are reflected in the improvement in 
physical and functional outcomes, but many children with JIA have periods 
of active disease despite current medical programmes. Vidqvist et al. (2013) 
reported several inflamed joints in the last year in 58% of patients with JIA 
with a median age of 19 years, in spite of medication. The present Study III 
confirms their result, where it appears that children with JIA have condylar 
alterations despite medical treatment. 
The involvement of the TMJ can influence the facial growth. Unfortunately, 
only 65 patients were included in the cephalometric study and they were only  
compared with a previous longitudinal study of healthy Swedish children 
(Thilander et al. 2005). Our cohort had more posterior rotated and 
retrognathic mandibles, in agreement with other studies (Kjellberg et al. 1995 
b , Sidiropoulou et al. 2001, Twilt et al. 2007, Twilt et al. 2008). We found 
no differences between boys and girls and we therefore decided not to split 
the cohort into genders.  We found a correlation between condylar alterations 
and a change in the growth pattern of the mandible, which others have also 
found (Larheim et al. 1981, Kjellberg et al. 1995 b, Hanna et al. 1996, 
Sidiropoulou et al. 2001, Twilt et al. 2007, Twilt et al. 2008). 
The way disease activity is correlated to facial growth is uncertain and many 
studies are cross-sectional. In our study of the 65 children with JIA, we were  
unable to see that many active disease periods were associated with any of 
the 12 cephalometric variables, but our study cohort was small. Billiau et al. 
(2007) found no association between disease activity and facial growth. 
Arvidsson et al. (2010) re-examined 60 adult patients with JIA after an 
average of 27 years. Patients with facial growth disturbances had more severe 
disease than patients with normal facial growth at both the initial examination 
and the re-examination. Serial records have shown that deformity may 
become worse with age and, the earlier the onset of the disease, the more 
abnormal the subsequent mandibular development (Barriga et al. 1974, 
Turpin 1989, Svensson et al. 2000). Twilt et al. (2007) revealed that the 
radiographic signs of condylar damage were worse five years later in a few 
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children that exhibited particularly high disease activity at the time of the re-
examination. 
Patients with JIA appear to undergo a change in facial growth pattern and it 
appears to be aggravated with condylar alterations. The relationship between 
disease activity over time and facial growth needs to be studied in larger 
cohorts. 
5.5 Representativity of the study population 
One weakness in the first study is that only patients with polyarticular and 
oligoarticular arthritis were included. The ILAR classification did not exist in 
1986 and the patients in Study I were therefore not diagnosed according to 
the ILAR criteria. The sample was relatively small, but previous studies have 
shown a regression of disease of 25-50% (Narayanan et al. 2002, Flato et al. 
2003, Fantini et al. 2003, Wallace et al. 2005), which is in agreement with 
this cohort. 
The data in Study II-IV were collected retrospectively, were not 
populationbased and were only discussed in relation to previous studies, 
which runs the risk of selection bias with an over-representation of severe 
cases. The merged study cohort was representative of the ILAR categories, 
gender and age in a distribution resembling cohorts from epidemiological 
studies. 
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6 CONCLUSION 
Adult patients, with an earlier diagnosis of JIA, report more pain and 
dysfunction in the orofacial or cervical regions compared with healthy 
individuals. This means that JIA patients run a higher risk of developing 
dysfunction in the masticatory system. 
There are associations between orofacial signs and symptoms and overall 
disease activity assessed for two years in children with JIA diagnosed 
according to the ILAR.    
TMJ damage, evaluated as condylar alterations on panoramic radiographs, 
was fairly common in our cohort of patients with JIA and alterations have 
been found to correlate with synovitis (Abramowicz et al. 2014). The unique 
anatomy of the TMJ, with a thin layer of fibrocartilage at the surface of the 
condylar head, and the biochemical composition make it susceptible to 
damage caused by arthritis (Ringold et al. 2009). The results suggest, within 
the limits of this observational study, that active disease over time appears to 
increase the risk of alterations to the TMJs despite medication.  
Patients with JIA have a changed facial growth pattern compared with 
healthy children. Study IV indicates that patients with condylar alterations 
have more retrognathia and a posterior rotated mandible. We were unable to 
confirm that high disease activity influences the facial growth pattern in 
patients with JIA, but our study cohort was small. Longer follow-up studies 
and further prospective studies with the emphasis on the way the growth 
pattern can be influenced are needed. 
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7 FUTURE PERSPECTIVES 
An early and correct TMJ diagnosis in patients with JIA is important in order 
to treat and prevent a negative effect primarily on the TMJs and secondarily 
on craniofacial development.  
There is a lack of consensus on when to treat and how to treat JIA in terms of 
the TMJ. In our cohort, we found condylar alterations despite medication, 
even if the patients were given the new biological agents. Can we reduce the 
risk of permanent joint damage by general medication or by local treatment 
with corticosteroid injections? Can we influence craniofacial growth with the 
new biological agents? What agent is the best to treat TMJ arthritis? 
As yet, current medical programmes have not been specified for the TMJ and 
more knowledge is needed in this area. Longer follow-up studies and further 
prospective studies, with the emphasis on the progress of TMJ arthritis and 
the influence of facial growth, are necessary. The need for prospective studies 
to find risk factors for TMJ involvement have previously been emphasised 
(Müller et al. 2009) and answering these question must surely be valuable. 
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